New scan could reveal how well immunotherapy works in real time
NCT ID NCT06534190
First seen Feb 14, 2026 · Last updated May 11, 2026 · Updated 11 times
Summary
This study tests a special imaging agent (89Zr-DF-Crefmirlimab) that helps PET scans show where immune cells called CD8 T-cells are in the body. About 30 adults with advanced solid tumors will receive this agent before and during standard immunotherapy. The goal is to see if the scan can predict or track how well the immune system attacks the cancer, which could help doctors personalize treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Center Groningen
RECRUITINGGroningen, 9713 GZ, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Cambridge
NOT_YET_RECRUITINGCambridge, CB2 1TN, United Kingdom
Contact
Contact
-
VUMC
RECRUITINGAmsterdam, 1081 HV, Netherlands
Contact
Contact
-
Vall d'Hebron Institute of Oncology (VHIO) / Vall d'Hebron Institute Research (VHIR)
NOT_YET_RECRUITINGBarcelona, 08035, Spain
Contact
Contact
Conditions
Explore the condition pages connected to this study.